Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Annexon, Inc. stock logo
ANNX
Annexon
$4.44
-2.2%
$5.71
$1.57
$8.40
$399.73M1.141.50 million shs840,796 shs
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
$27.93
+3.2%
$34.41
$17.52
$43.81
$751.88M2.6456,162 shs314,074 shs
Epizyme, Inc. stock logo
EPZM
Epizyme
$1.47
$1.47
$0.41
$5.80
$247.44M-0.413.23 million shs7,960 shs
Organigram Holdings Inc. stock logo
OGI
Organigram
$1.95
+2.6%
$2.09
$0.97
$2.91
$201.24M1.091.37 million shs1.11 million shs
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
$17.64
-2.9%
$20.41
$16.90
$36.64
$493.57M1.6218,652 shs277,632 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Annexon, Inc. stock logo
ANNX
Annexon
-0.33%-20.82%-33.16%-3.09%-18.98%
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
+4.16%-7.68%-20.18%-21.86%-2.24%
Epizyme, Inc. stock logo
EPZM
Epizyme
0.00%0.00%0.00%0.00%0.00%
Organigram Holdings Inc. stock logo
OGI
Organigram
+0.53%+1.06%-30.15%+1.06%-5.00%
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
-1.36%+3.18%-3.04%-29.53%-40.67%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Annexon, Inc. stock logo
ANNX
Annexon
3.3206 of 5 stars
4.53.00.00.01.82.50.6
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
1.9032 of 5 stars
3.50.00.00.02.53.30.6
Epizyme, Inc. stock logo
EPZM
Epizyme
N/AN/AN/AN/AN/AN/AN/AN/A
Organigram Holdings Inc. stock logo
OGI
Organigram
N/AN/AN/AN/AN/AN/AN/AN/A
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
1.2894 of 5 stars
0.03.01.72.61.21.71.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Annexon, Inc. stock logo
ANNX
Annexon
3.00
Buy$14.43224.97% Upside
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
3.00
Buy$61.33119.60% Upside
Epizyme, Inc. stock logo
EPZM
Epizyme
N/AN/AN/AN/A
Organigram Holdings Inc. stock logo
OGI
Organigram
3.00
BuyN/AN/A
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
1.00
SellN/AN/A

Current Analyst Ratings

Latest OGI, ANNX, EPZM, RDUS, and ARCT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2024
Organigram Holdings Inc. stock logo
OGI
Organigram
Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy
4/11/2024
Annexon, Inc. stock logo
ANNX
Annexon
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$16.00
4/3/2024
Annexon, Inc. stock logo
ANNX
Annexon
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight
4/1/2024
Annexon, Inc. stock logo
ANNX
Annexon
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$11.00 ➝ $13.00
3/28/2024
Annexon, Inc. stock logo
ANNX
Annexon
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$7.00 ➝ $10.00
3/27/2024
Annexon, Inc. stock logo
ANNX
Annexon
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$11.00 ➝ $12.00
3/27/2024
Annexon, Inc. stock logo
ANNX
Annexon
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$30.00
3/27/2024
Annexon, Inc. stock logo
ANNX
Annexon
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$16.00
3/20/2024
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$60.00
3/8/2024
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
3/4/2024
Annexon, Inc. stock logo
ANNX
Annexon
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$30.00
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Annexon, Inc. stock logo
ANNX
Annexon
N/AN/AN/AN/A$3.20 per shareN/A
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
$169.93M4.42N/AN/A$10.42 per share2.68
Epizyme, Inc. stock logo
EPZM
Epizyme
$37.43M6.61N/AN/A($0.54) per share-2.72
Organigram Holdings Inc. stock logo
OGI
Organigram
$120.01M1.68N/AN/A$2.48 per share0.79
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
$2.88B0.17$3.96 per share4.46$33.14 per share0.53

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Annexon, Inc. stock logo
ANNX
Annexon
-$134.24M-$1.78N/AN/AN/AN/A-66.54%-53.52%5/13/2024 (Estimated)
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
-$29.73M-$1.04N/A5.48N/A-15.65%-18.22%-11.95%5/14/2024 (Estimated)
Epizyme, Inc. stock logo
EPZM
Epizyme
-$251.12M-$1.72N/AN/AN/A-391.90%-2,459.33%-69.74%N/A
Organigram Holdings Inc. stock logo
OGI
Organigram
-$184.34M-$0.80N/AN/AN/A-173.48%-30.94%-27.70%4/23/2024 (Estimated)
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
-$25.79M-$2.28N/A19.38N/A-2.28%-1.73%-0.88%6/25/2024 (Estimated)

Latest OGI, ANNX, EPZM, RDUS, and ARCT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/4/2024Q2 2024
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
-$1.09-$1.04+$0.05-$0.89$626.35 million$621.06 million    
3/26/2024Q4 2023
Annexon, Inc. stock logo
ANNX
Annexon
-$0.45-$0.36+$0.09-$0.36N/AN/A
3/7/2024Q4 2023
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
-$1.69-$0.32+$1.37-$0.32$64.14 million$33.99 million
2/13/2024Q1 2024
Organigram Holdings Inc. stock logo
OGI
Organigram
-$0.10-$0.14-$0.04-$0.14$28.61 million$26.78 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Annexon, Inc. stock logo
ANNX
Annexon
N/AN/AN/AN/AN/A
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
N/AN/AN/AN/AN/A
Epizyme, Inc. stock logo
EPZM
Epizyme
N/AN/AN/AN/AN/A
Organigram Holdings Inc. stock logo
OGI
Organigram
N/AN/AN/AN/AN/A
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
$0.754.25%N/AN/A N/A

Latest OGI, ANNX, EPZM, RDUS, and ARCT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/1/2024
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
quarterly$0.18753.7%4/19/20244/22/20245/6/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Annexon, Inc. stock logo
ANNX
Annexon
N/A
14.72
14.72
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
N/A
4.72
4.72
Epizyme, Inc. stock logo
EPZM
Epizyme
N/A
5.35
5.19
Organigram Holdings Inc. stock logo
OGI
Organigram
N/A
4.28
2.11
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
0.43
1.96
0.92

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Annexon, Inc. stock logo
ANNX
Annexon
N/A
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
94.54%
Epizyme, Inc. stock logo
EPZM
Epizyme
76.45%
Organigram Holdings Inc. stock logo
OGI
Organigram
34.63%
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
78.11%

Insider Ownership

CompanyInsider Ownership
Annexon, Inc. stock logo
ANNX
Annexon
19.11%
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
13.80%
Epizyme, Inc. stock logo
EPZM
Epizyme
23.40%
Organigram Holdings Inc. stock logo
OGI
Organigram
0.09%
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
5.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Annexon, Inc. stock logo
ANNX
Annexon
7190.03 million72.82 millionOptionable
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
18026.92 million23.20 millionOptionable
Epizyme, Inc. stock logo
EPZM
Epizyme
250168.33 million128.97 millionOptionable
Organigram Holdings Inc. stock logo
OGI
Organigram
984103.20 million103.11 millionOptionable
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
3,35327.98 million26.39 millionOptionable

OGI, ANNX, EPZM, RDUS, and ARCT Headlines

SourceHeadline
Radius Recycling (NASDAQ:RDUS) Shares Gap Up to $17.43Radius Recycling (NASDAQ:RDUS) Shares Gap Up to $17.43
marketbeat.com - April 17 at 1:11 PM
Radius Announces Presentation of Data on TYMLOS (abaloparatide) at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal DiseasesRadius Announces Presentation of Data on TYMLOS (abaloparatide) at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
finance.yahoo.com - April 16 at 9:27 AM
Radius Recycling (NASDAQ:RDUS) Shares Up 3.6%Radius Recycling (NASDAQ:RDUS) Shares Up 3.6%
marketbeat.com - April 15 at 4:39 PM
Radius Recycling (NASDAQ:RDUS)  Shares Down 6.9% Radius Recycling (NASDAQ:RDUS) Shares Down 6.9%
marketbeat.com - April 10 at 2:52 PM
Radius Health, Inc. (NASDAQ:RDUS) Q2 2024 Earnings Call TranscriptRadius Health, Inc. (NASDAQ:RDUS) Q2 2024 Earnings Call Transcript
finance.yahoo.com - April 8 at 9:35 AM
Radius Recycling (NASDAQ:RDUS) Is Due To Pay A Dividend Of $0.1875Radius Recycling (NASDAQ:RDUS) Is Due To Pay A Dividend Of $0.1875
uk.finance.yahoo.com - April 7 at 7:50 PM
Radius Recycling declares $0.1875 dividendRadius Recycling declares $0.1875 dividend
seekingalpha.com - April 6 at 2:11 PM
Radius Recycling (NASDAQ:RDUS) Downgraded by StockNews.comRadius Recycling (NASDAQ:RDUS) Downgraded by StockNews.com
marketbeat.com - April 5 at 11:10 PM
Radius Recycling, Inc. (RDUS) Q2 2024 Earnings Call TranscriptRadius Recycling, Inc. (RDUS) Q2 2024 Earnings Call Transcript
seekingalpha.com - April 5 at 10:55 PM
Radius Recycling Inc (RDUS) Q2 2024 Earnings Call Transcript Highlights: Strategic Adjustments ...Radius Recycling Inc (RDUS) Q2 2024 Earnings Call Transcript Highlights: Strategic Adjustments ...
finance.yahoo.com - April 5 at 5:55 PM
Radius Recycling, Inc. (NASDAQ:RDUS) Announces $0.19 Quarterly DividendRadius Recycling, Inc. (NASDAQ:RDUS) Announces $0.19 Quarterly Dividend
marketbeat.com - April 5 at 5:19 PM
Radius Recycling (NASDAQ:RDUS) Announces  Earnings ResultsRadius Recycling (NASDAQ:RDUS) Announces Earnings Results
marketbeat.com - April 5 at 8:23 AM
Radius Recycling Second Quarter 2024 Earnings: EPS Misses ExpectationsRadius Recycling Second Quarter 2024 Earnings: EPS Misses Expectations
finance.yahoo.com - April 5 at 7:50 AM
Radius Recycling Reports Q2 Results; American Battery Awarded Another $40.5 Million; Nexa Prices $600 Million Offering And More: Thursdays Top Mining StoriesRadius Recycling Reports Q2 Results; American Battery Awarded Another $40.5 Million; Nexa Prices $600 Million Offering And More: Thursday's Top Mining Stories
benzinga.com - April 4 at 6:02 PM
Radius Recycling (NASDAQ:RDUS) Hits New 12-Month Low at $17.04Radius Recycling (NASDAQ:RDUS) Hits New 12-Month Low at $17.04
marketbeat.com - April 4 at 1:20 PM
Radius Recycling, Inc. 2024 Q2 - Results - Earnings Call PresentationRadius Recycling, Inc. 2024 Q2 - Results - Earnings Call Presentation
seekingalpha.com - April 4 at 11:56 AM
Stocks Rise Before the Open as Investors Shift Focus to Key U.S. Jobs Data, ECB Minutes on TapStocks Rise Before the Open as Investors Shift Focus to Key U.S. Jobs Data, ECB Minutes on Tap
msn.com - April 4 at 10:59 AM
Radius Recycling: Fiscal Q2 Earnings SnapshotRadius Recycling: Fiscal Q2 Earnings Snapshot
finance.yahoo.com - April 4 at 10:59 AM
Radius Recycling Inc (RDUS) Misses Earnings Predictions with Q2 Fiscal 2024 ResultsRadius Recycling Inc (RDUS) Misses Earnings Predictions with Q2 Fiscal 2024 Results
finance.yahoo.com - April 4 at 10:59 AM
Radius Recycling Reports Second Quarter Fiscal 2024 Financial ResultsRadius Recycling Reports Second Quarter Fiscal 2024 Financial Results
globenewswire.com - April 4 at 8:00 AM
Recycling plant on Darrington Road on fireRecycling plant on Darrington Road on fire
kvia.com - March 28 at 12:29 PM
Analysts Estimate Radius Recycling (RDUS) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Radius Recycling (RDUS) to Report a Decline in Earnings: What to Look Out for
zacks.com - March 28 at 11:00 AM
RDUS Sep 2024 30.000 callRDUS Sep 2024 30.000 call
finance.yahoo.com - March 20 at 10:47 PM
RDUS May 2024 30.000 callRDUS May 2024 30.000 call
finance.yahoo.com - March 20 at 12:45 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Annexon logo

Annexon

NASDAQ:ANNX
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase II clinical trial for the treatment of amyotrophic lateral sclerosis. The company is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.
Arcturus Therapeutics logo

Arcturus Therapeutics

NASDAQ:ARCT
Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms include LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-154 (LUNAR-COV19), a mRNA vaccine candidate that is in Phase 3 arm of a Phase 1/2/3 study in Vietnam for the treatment of COVID-19, as well as ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate for cystic fibrosis. Its product pipeline includes, ARCT-2301 for bivalent: ancestral/omicron which is in Phase 3; ARCT-2303 for monovalent that is in Phase 3; ARCT-2138 for quadrivalent which is in Phase 1; and LUNAR-FLU which is in pre-clinical trial. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.
Epizyme logo

Epizyme

NASDAQ:EPZM
Epizyme, Inc., a commercial-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines for patients with cancer and other diseases in the United States. The company offers Tazemetostat for the treatment of metastatic or locally advanced epithelioid sarcoma for adults and pediatric patients. It also develops R-CHOP in front-line patients with high risk diffuse large B-cell lymphoma; and PARP inhibitor in patients with PARPi-resistant solid tumors, such as castration-resistant prostate cancer, small cell lung cancer, and others. In addition, the company develops Tazemetostat in patients with INI1-negative tumors in adults and pediatrics; PRMT5 inhibitor for patients with solid tumors; and PRMT1 inhibitor. It has collaboration agreements with Roche Molecular Systems, Inc.; Lymphoma Academic Research Organization; Eisai Co. Ltd.; HUTCHMED (China) Limited; and Roche Sequencing Solutions, Inc. The company was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Organigram logo

Organigram

NASDAQ:OGI
Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.
Radius Recycling logo

Radius Recycling

NASDAQ:RDUS
Radius Recycling, Inc. recycles ferrous and nonferrous metal, and manufactures finished steel products worldwide. The company acquires, processes, and recycles salvaged vehicles, rail cars, home appliances, industrial machinery, manufacturing scrap, and construction and demolition scrap. It offers recycled ferrous metal, a feedstock used in the production of finished steel products; and nonferrous products, including mixed metal joint products recovered from the shredding process, such as zorba, zurik, aluminum, copper, stainless steel, nickel, brass, titanium, lead, and high temperature alloys. The company also procures salvaged vehicles and sells serviceable used auto parts from these vehicles through its retail self-service auto parts stores. In addition, it produces various finished steel products using ferrous recycled metal and other raw materials, as well as semi-finished goods, which include billets; and finished goods consisting of rebar, coiled rebar, wire rods, merchant bars, and other specialty products. Further, the company sells catalytic converters to specialty processors that extract the nonferrous precious metals, including platinum, palladium, and rhodium; and ferrous and nonferrous recycled metal products to steel mills, foundries, refineries, smelters, wholesalers, and recycled metal processors, as well as finished steel customers, such as steel service centers, construction industry subcontractors, steel fabricators, wire drawers, and major farm and wood products suppliers. It also provides recycling and related services, including scrap brokerage, certified destruction, automotive parts recycling, railcar dismantling, and reverse logistics under 3PR brand name. Radius Recycling, Inc. was formerly known as Schnitzer Steel Industries, Inc. and changed its name to Radius Recycling, Inc. in January 2024. Radius Recycling, Inc. was founded in 1906 and is headquartered in Portland, Oregon.